Neurodiab (@neurodiab_eu) 's Twitter Profile
Neurodiab

@neurodiab_eu

Neurodiab is the study group born in 1991 with the special responsibility for promoting research and education in diabetic neuropathy

ID: 1468644755290607618

calendar_today08-12-2021 18:13:19

255 Tweet

280 Followers

35 Following

Mitra Tavakoli (@mitratava) 's Twitter Profile Photo

"Congratulations to Prof. Solomon Tesfaye, Prof. Dan Ziegler, and Prof. Paul Valensi on receiving the NeuroDiab Life Achievement Award! Their groundbreaking contributions have advanced knowledge and improved many lives. Neurodiab Vincenza Spallone Solomon Tesfaye

"Congratulations to Prof. Solomon Tesfaye, Prof. Dan Ziegler, and Prof. Paul Valensi on receiving the NeuroDiab Life Achievement Award! Their groundbreaking contributions have advanced knowledge and improved many lives. <a href="/Neurodiab_eu/">Neurodiab</a> <a href="/VinceSpallone/">Vincenza Spallone</a> <a href="/solomon19400/">Solomon Tesfaye</a>
Abd Tahrani (@abdtahrani) 's Twitter Profile Photo

The utility of high frequency spinal cord stimulation in painful #diabetes #neuropathy . Very nice talk, potential disease modifying role based on improvement of protective sensation (unclear MoA) , high efficacy in terms of pain. #neurodiab2024 Neurodiab

The utility of high frequency spinal cord stimulation in painful #diabetes #neuropathy . Very nice talk, potential disease modifying role based on improvement of protective sensation (unclear MoA) , high efficacy in terms of pain. #neurodiab2024 <a href="/Neurodiab_eu/">Neurodiab</a>
Abd Tahrani (@abdtahrani) 's Twitter Profile Photo

Interesting data from Aarhus University showing the development and progression of #neuropathy longitudinally. General worsening but a small group regress from definite to probable neuropathy. Age, waist & Trigs were imp predictors #neurodiab2024 Neurodiab ⬇️

Interesting data from Aarhus University showing the development and progression of #neuropathy longitudinally. General worsening but a small group regress from definite to probable neuropathy. Age, waist &amp; Trigs were imp predictors #neurodiab2024 <a href="/Neurodiab_eu/">Neurodiab</a> ⬇️
Abd Tahrani (@abdtahrani) 's Twitter Profile Photo

Beautiful talk from David Bennett, University of Oxford re genetics of painful #diabetes #neuropathy . Mostly related to ion channels, some affecting the “break” system on nerve excitability. Mental health was better predictor than genetics ⬇️ #neurodiab2024 Neurodiab

Beautiful talk from David Bennett, University of Oxford re genetics of painful #diabetes #neuropathy . Mostly related to ion channels, some affecting the “break” system on nerve excitability. Mental health was better predictor than genetics ⬇️ #neurodiab2024 <a href="/Neurodiab_eu/">Neurodiab</a>
Mitra Tavakoli (@mitratava) 's Twitter Profile Photo

Insightful talk by Prof. Andrea Truini on the effectiveness and diagnostic value of various objective tests for diabetic neuropathy. Neurodiab

Insightful talk by Prof. Andrea Truini on the effectiveness and diagnostic value of various objective tests for diabetic neuropathy. <a href="/Neurodiab_eu/">Neurodiab</a>
Mitra Tavakoli (@mitratava) 's Twitter Profile Photo

Remarkable talk by Prof. Solomon Tesfaye on reviewing endpoints for diagnosing diabetic neuropathy, highlighting the need for consensus among experts in this critical area. Neurodiab

Remarkable talk by Prof. Solomon Tesfaye on reviewing endpoints for diagnosing diabetic neuropathy, highlighting the need for consensus among experts in this critical area. <a href="/Neurodiab_eu/">Neurodiab</a>
Mitra Tavakoli (@mitratava) 's Twitter Profile Photo

An exceptional master class by Prof Fabrizio Benedetti on the placebo and nocebo effects in clinical trials for diabetic neuropathy, offering profound insights into how patient expectations can significantly influence trial outcomes and therapeutic responses.Neurodiab

An exceptional master class by Prof Fabrizio Benedetti on the placebo and nocebo effects in clinical trials for diabetic neuropathy, offering profound insights into how patient expectations can significantly influence trial outcomes and therapeutic responses.<a href="/Neurodiab_eu/">Neurodiab</a>
Mitra Tavakoli (@mitratava) 's Twitter Profile Photo

Pain phenotyping: a step forward towards precision medicine. An elegant and insightful talk by Prof. Ralf Baron, shedding light on personalized approaches to chronic pain management. #PainPhenotyping #PrecisionMedicine Neurodiab

Pain phenotyping: a step forward towards precision medicine. An elegant and insightful talk by Prof. Ralf Baron, shedding light on personalized approaches to chronic pain management. #PainPhenotyping #PrecisionMedicine <a href="/Neurodiab_eu/">Neurodiab</a>
Niels Ejskjaer (@nielsejskjaer) 's Twitter Profile Photo

Final session at #NeuroDiab2024, chaired by Johan Røikjer & #CarlaGreco👍 - “Perspectives in Autonomic Neuropathy” - Grand clinical finale🎉 expert with deep insights into 1) CAN diagnosis, 2) gastroparesis and 3) bladder dysfunction 🇩🇰🇮🇹 - #StenoNord Aalborg Universitetshospital Region Nordjylland

Final session at #NeuroDiab2024, chaired by <a href="/johanroeikjer/">Johan Røikjer</a> &amp; #CarlaGreco👍 - “Perspectives in Autonomic Neuropathy” - 
Grand clinical finale🎉 expert with deep insights into 1) CAN diagnosis, 2) gastroparesis and 3) bladder dysfunction
🇩🇰🇮🇹
- #StenoNord <a href="/AalborgUH/">Aalborg Universitetshospital</a> <a href="/Reg_Nord/">Region Nordjylland</a>
Neurodiab (@neurodiab_eu) 's Twitter Profile Photo

Painful and painless diabetic peripheral neuropathy prevalence in the Northern Danish Region On Neurodiab website a signaling of articles on #diabeticneuropathy The 139th NEUROdiab Publication News is by Fabiana Picconi (neurodiab.eu/publication-ne…)

Painful and painless diabetic peripheral neuropathy prevalence in the Northern Danish Region
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 139th NEUROdiab Publication News is by Fabiana Picconi (neurodiab.eu/publication-ne…)
Neurodiab (@neurodiab_eu) 's Twitter Profile Photo

Don't miss NEUROdiab symposium at the 60th EASD Annual Meeting in Madrid or online 12 September 2024 / 09:00 – 11:00 CEST / Retiro Hall

Don't miss NEUROdiab symposium at the 60th EASD Annual Meeting in Madrid or online  
12 September 2024 / 09:00 – 11:00 CEST / Retiro Hall
Neurodiab (@neurodiab_eu) 's Twitter Profile Photo

At the 60th Annual Meeting of EASD, the 39th Camillo Golgi Lecture was held by Rodica Pop-Busui Congratulations on this well-deserved award

At the 60th Annual Meeting of EASD, the 39th Camillo Golgi Lecture was held by Rodica Pop-Busui
Congratulations on this well-deserved award
Abd Tahrani (@abdtahrani) 's Twitter Profile Photo

Very nice talk from Uazman Alam about the use of AI in neuropathy. Very encouraging progress but not ready for prime time as yet. This highlights the need for large collaboration across multiple cohorts in order to advance the field #EASD2024 #diabetes #obesity Neurodiab

Very nice talk from <a href="/AlamUazman/">Uazman Alam</a> about the use of AI in neuropathy. Very encouraging progress but not ready for prime time as yet. This highlights the need for large collaboration across multiple cohorts in order to advance the field #EASD2024 #diabetes #obesity <a href="/Neurodiab_eu/">Neurodiab</a>
Abd Tahrani (@abdtahrani) 's Twitter Profile Photo

Disease modifying treatments in #diabetes neuropathy. Challenges and opportunities that need to be addressed across academia and industry, with big and clear unmet clinical and health needs. #EASD2024 #obesity Neurodiab

Disease modifying treatments in #diabetes neuropathy. Challenges and opportunities that need to be addressed across academia and industry, with big and clear unmet clinical and health needs. #EASD2024 #obesity <a href="/Neurodiab_eu/">Neurodiab</a>
Prash Vas (@prashvas) 's Twitter Profile Photo

Superb #NEUROdiab2024 Symp at #EASD2024”🇪🇸 The least mechanistically understood of DM compl, now getting a boost with emergence of #AI and newer putative therapies. Exciting times EASD Neurodiab Niels Ejskjaer

Superb  #NEUROdiab2024 Symp  at #EASD2024”🇪🇸
The least mechanistically understood of DM compl, now getting a boost with emergence of #AI and newer putative therapies. Exciting times 

<a href="/EASDnews/">EASD</a> <a href="/Neurodiab_eu/">Neurodiab</a> <a href="/NielsEjskjaer/">Niels Ejskjaer</a>